Home » Topics » Regulatory » Patents

Patents
RSS

More on AMPA antagonists under study at Pfizer

Jan. 20, 1999

Ortho-McNeil reports new treatments for BPH

Jan. 20, 1999

Melatonergic agents in development at Bristol-Myers Squibb

Jan. 20, 1999

Nitromethyl ketones from Merck KGaA protect against diabetic complications

Jan. 20, 1999

Roche presents new compound for hyperproliferative skin disorders

Jan. 19, 1999

Cyanoenamines as potassium channel modulators

Jan. 19, 1999

New broad-spectrum antibacterial series patented by Bayer

Jan. 19, 1999

Cancer Research Campaign Technology evaluates new antitumor trimelamol analogues

Jan. 19, 1999

AMPA antagonists and their use described by Pfizer

Jan. 19, 1999

Tricyclic antiproliferative agents revealed by Schering-Plough

Jan. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...